14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 GERN stock ended at $3.81. This is 1.55% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.31% from a day low at $3.78 to a day high of $3.90.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Geron Corporation prices

Date Open High Low Close Volume
Apr 09, 2021 $1.53 $1.53 $1.48 $1.48 1 859 527
Apr 08, 2021 $1.55 $1.56 $1.50 $1.52 1 729 213
Apr 07, 2021 $1.58 $1.60 $1.52 $1.52 1 462 699
Apr 06, 2021 $1.60 $1.64 $1.58 $1.59 1 398 540
Apr 05, 2021 $1.65 $1.65 $1.58 $1.60 1 850 102
Apr 01, 2021 $1.60 $1.64 $1.58 $1.62 1 224 382
Mar 31, 2021 $1.54 $1.62 $1.53 $1.58 2 569 750
Mar 30, 2021 $1.56 $1.57 $1.49 $1.52 2 015 696
Mar 29, 2021 $1.58 $1.59 $1.51 $1.53 3 057 207
Mar 26, 2021 $1.62 $1.63 $1.54 $1.59 2 588 784
Mar 25, 2021 $1.56 $1.64 $1.54 $1.62 2 754 622
Mar 24, 2021 $1.69 $1.69 $1.55 $1.55 4 080 691
Mar 23, 2021 $1.80 $1.80 $1.65 $1.65 4 309 150
Mar 22, 2021 $1.81 $1.85 $1.78 $1.79 1 708 843
Mar 19, 2021 $1.76 $1.86 $1.74 $1.83 9 178 617
Mar 18, 2021 $1.77 $1.83 $1.74 $1.75 3 845 497
Mar 17, 2021 $1.74 $1.81 $1.71 $1.81 3 502 113
Mar 16, 2021 $1.70 $1.78 $1.69 $1.77 5 311 692
Mar 15, 2021 $1.70 $1.73 $1.68 $1.72 4 023 067
Mar 12, 2021 $1.75 $1.77 $1.70 $1.72 6 921 458
Mar 11, 2021 $1.86 $1.90 $1.82 $1.89 2 778 856
Mar 10, 2021 $1.91 $1.91 $1.80 $1.83 2 152 016
Mar 09, 2021 $1.78 $1.87 $1.78 $1.86 2 603 177
Mar 08, 2021 $1.80 $1.84 $1.75 $1.77 2 531 707
Mar 05, 2021 $1.76 $1.81 $1.68 $1.80 5 105 618
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT